ArticleCureus2025
Cavernous Hemangioma: A Rare Adrenal Tumor Associated With Hyperaldosteronism.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Coexisting adrenal hemangioma and aldosterone-producing micronodule presented as adrenal incidentaloma.JCEM case reports · 2026Article
- Adrenal cavernous hemangioma misdiagnosed as pheochromocytoma: a case report.Urology case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adrenal cavernous hemangiomas are rare benign venous malformations characterized by vascular dysmorphogenesis. A 53-year-old male patient was referred for a surgical consultation with a 5 cm heterogeneous, lipid-poor, incidental left adrenal mass. It was detected on a computed tomography (CT) scan performed for left upper quadrant pain. His past medical history was significant for poorly-controlled hypertension on a multi-drug regimen, anxiety, headaches, insomnia, and palpitations. Laboratory testing performed by his primary care physician revealed elevated plasma catecholamines, which were concerning for pheochromocytoma. A repeat workup by endocrinology and endocrine surgery showed biochemical evidence of primary hyperaldosteronism with an aldosterone/plasma renin ratio of 36.8 and normal plasma catecholamines and metanephrines. Due to the biochemical workup, size, and radiological features of the mass, a decision to proceed with a left adrenalectomy was made. The patient was started on phenoxybenzamine two weeks before surgery due to a high index of clinical suspicion for a pheochromocytoma, despite the equivocal biochemical workup. Surgical pathology revealed a cavernous hemangioma with pseudonodular thickening of the adrenal cortex without evidence of malignancy, adrenal adenoma, or pheochromocytoma. On follow-up, the patient was on fewer antihypertensive medications with normal blood pressure and a normalized aldosterone/plasma renin ratio. A diagnosis of cavernous hemangioma should be considered for adrenal masses of uncertain biology and biochemical activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.